Structured Labeling Services: Structured Product Labeling Explained

When you plan to export cosmetics, OTC drugs, pharmaceuticals, or food products to the United States, understanding Structured Product Labeling (SPL) is essential. The U.S. Food and Drug Administration (FDA) requires product labeling to be submitted in a specific electronic format to ensure consistency, accuracy, and regulatory compliance. This post breaks down what SPL is, why it matters, and how you can navigate the process effectively.

What Is Structured Product Labeling?

Structured Product Labeling is an FDA-mandated standard for submitting product labeling information electronically. It uses Extensible Markup Language (XML) to encode the content and format of labels for drugs, biologics, and other regulated products. The SPL format is defined in the FDA’s 21 CFR Part 207 and is designed to make label information machine-readable and easily searchable.

The SPL file contains detailed information such as:

• Product name and description

• Ingredients and composition

• Dosage and administration instructions

• Warnings and precautions

• Manufacturer and distributor details

  
  

This structured approach replaces traditional paper or PDF labels with a digital format that supports regulatory review, product tracking, and public access.

Eye-level view of a computer screen displaying XML code for product labeling

Why SPL Matters for Exporters

If you are exporting to the U.S., the FDA requires that your product labels be submitted in SPL format as part of the Drug Listing process. This is mandatory for all prescription and over-the-counter drugs, biologics, and certain medical devices. Failure to comply can result in import delays, product holds, or refusal of entry.

For cosmetic and food products, while SPL is not always mandatory, having your labeling structured and compliant with FDA guidelines can streamline your registration and approval processes. It also helps you avoid costly relabeling or regulatory issues once your products enter the U.S. market.

How Structured Labeling Services Support Your Compliance

Navigating SPL requirements can be complex, especially if you are unfamiliar with FDA regulations or lack in-house regulatory expertise. This is where structured labeling services come into play. These services specialize in preparing, validating, and submitting SPL files that meet FDA standards.

Key Benefits of Using Structured Labeling Services

• Regulatory Expertise: They understand FDA rules, including 21 CFR Part 207 and related guidances.

• Accurate Data Entry: Ensures all label content is correctly encoded in XML format.

• Validation and Quality Checks: SPL files are tested against FDA’s SPL validation tools to avoid submission errors.

• Timely Submission: They handle electronic submissions through the FDA’s Electronic Submissions Gateway (ESG).

• Ongoing Updates: Label changes can be updated efficiently to maintain compliance.

  
  

By outsourcing this critical task, you reduce the risk of non-compliance and free your team to focus on other business priorities.

Close-up view of a regulatory expert reviewing product label documents

Step-by-Step Process for SPL Submission

Understanding the exact steps involved in SPL submission helps you plan and allocate resources effectively. Here is a typical workflow:

1. Label Content Preparation

   Gather all label information including product details, ingredients, usage instructions, and safety warnings. Ensure the content complies with FDA labeling requirements under 21 CFR Parts 201 and 207.

   
   

2. XML Encoding

   Convert the label content into the SPL XML format. This requires specialized software or services that can create compliant SPL files.

   
   

3. Validation

   Use FDA’s SPL validation tools to check for errors or missing information. The FDA provides a free SPL Validator tool available on their website.

   
   

4. Submission via ESG

   Submit the validated SPL file electronically through the FDA’s Electronic Submissions Gateway. This is the official channel for all SPL submissions.

   
   

5. FDA Review and Listing

   Once accepted, the FDA assigns a National Drug Code (NDC) labeler code and lists the product in their database. This listing is mandatory for marketing your product in the U.S.

   
   

6. Ongoing Updates

   Any label changes, such as formulation updates or new warnings, must be resubmitted in SPL format to maintain compliance.

   
   

Important Deadlines and Compliance Notes

• Drug Listing Deadline: All prescription and OTC drugs must be listed with the FDA before marketing in the U.S.

• Labeling Updates: Submit updated SPL files within 30 days of any label changes.

• Facility Registration: Your manufacturing facility must also be registered with the FDA as part of the compliance process.

  
  

Common Challenges and How to Overcome Them

Many foreign companies face hurdles when dealing with SPL requirements. Here are some common issues and practical solutions:

Challenge 1: Lack of In-House Regulatory Expertise

Solution: Partner with a U.S.-based regulatory consultant or service provider who offers structured product labeling services. They can guide you through FDA requirements and handle submissions on your behalf.

Challenge 2: Complex XML Formatting

Solution: Use specialized SPL software or outsource to experts who understand the technical details of XML encoding and FDA validation.

Challenge 3: Keeping Up with FDA Updates

Solution: Stay informed about FDA regulatory changes by subscribing to FDA newsletters and working with regulatory advisors who monitor compliance updates.

Challenge 4: Coordinating Labeling with Facility Registration

Solution: Ensure your FDA facility registration is completed and linked to your product listings. This coordination is critical for smooth product entry into the U.S. market.

Preparing for Your First SPL Submission

If this is your first time submitting SPL files, here are actionable recommendations to help you get started:

• Conduct a Label Audit: Review your current labels against FDA requirements to identify gaps.

• Engage a U.S. Agent: If you are a foreign company, appoint a legally designated U.S. Agent to handle FDA communications.

• Register Your Facility: Complete FDA facility registration early to avoid delays.

• Develop a Labeling Strategy: Plan how you will manage label updates and submissions over time.

• Test Your SPL Files: Use FDA’s validation tools before submission to catch errors early.

• Document Everything: Keep detailed records of submissions, approvals, and correspondence with the FDA.

  
  

By following these steps, you can reduce risks and ensure your products meet FDA expectations from day one.

Understanding and complying with Structured Product Labeling requirements is a critical step for any company exporting regulated products to the U.S. market. Leveraging expert support and following a clear submission process will help you avoid costly delays and maintain smooth market access.

If you want to ensure your labeling meets FDA standards and streamline your regulatory submissions, consider partnering with professionals who specialize in structured product labeling services. Their expertise can be invaluable in navigating the complexities of FDA compliance.

Next Steps: Navigating FDA Compliance Beyond SPL

Once your SPL submissions are in place, your focus should shift to maintaining ongoing compliance. This includes monitoring FDA updates, managing product recalls if necessary, and ensuring your facility registrations remain current. Staying proactive in these areas will protect your market access and reputation in the U.S. regulatory environment.